Nexgel Company Leadership
| NXGL Stock | USD 3.37 0.05 1.51% |
Nexgel's insiders are aggressively buying. The analysis of insiders' sentiment of trading Nexgel Inc stock suggests that most insiders are extremely bullish at this time. Nexgel employs about 19 people. The company is managed by 4 executives with a total tenure of roughly 45 years, averaging almost 11.0 years of service per executive, having 4.75 employees per reported executive.
Nexgel's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-08-23 | Steven Mark Glassman | Acquired 10000 @ 2.5 | View | ||
| 2024-03-01 | Scott Robert Henry | Acquired 23697 @ 2.11 | View | ||
| 2023-12-22 | Steven Mark Glassman | Acquired 3885 @ 2.2 | View |
Monitoring Nexgel's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Nexgel |
Nexgel's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Nexgel's future performance. Based on our forecasts, it is anticipated that Nexgel will maintain a workforce of about 19 employees by December 2024.Nexgel Management Team Effectiveness
The company has return on total asset (ROA) of (0.2316) % which means that it has lost $0.2316 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6431) %, meaning that it created substantial loss on money invested by shareholders. Nexgel's management efficiency ratios could be used to measure how well Nexgel manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.39. The value of Return On Capital Employed is expected to slide to -0.49. At this time, Nexgel's Intangible Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.13 this year, although the value of Total Current Assets will most likely fall to about 3.9 M.The value of Common Stock Shares Outstanding is expected to slide to about 5.4 M. The value of Net Loss is expected to slide to about (4.5 M)
Nexgel Workforce Comparison
Nexgel Inc is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 969. Nexgel claims roughly 19.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.68) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.73) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.73. Nexgel Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexgel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexgel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nexgel insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-12-01 | 12.0 | 12 | 1 | 58,974 | 4,000 |
| 2021-12-01 | 5.5 | 11 | 2 | 1,534,752 | 1,000,000 |
| 2021-03-01 | 1.0 | 2 | 2 | 2,050,000 | 500,000 |
Nexgel Notable Stakeholders
A Nexgel stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nexgel often face trade-offs trying to please all of them. Nexgel's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nexgel's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Adam Levy | President CEO | Profile | |
| David Stefansky | Ex Director | Profile | |
| Adam III | Chief Officer | Profile | |
| Gregory Robb | Vice Operations | Profile |
About Nexgel Management Performance
The success or failure of an entity such as Nexgel Inc often depends on how effective the management is. Nexgel management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nexgel management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nexgel management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.37) | (0.39) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.32) | (0.33) | |
| Return On Equity | (0.67) | (0.71) |
Nexgel Workforce Analysis
Traditionally, organizations such as Nexgel use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nexgel within its industry.Nexgel Manpower Efficiency
Return on Nexgel Manpower
| Revenue Per Employee | 215.2K | |
| Revenue Per Executive | 1M | |
| Net Loss Per Employee | 166.2K | |
| Net Loss Per Executive | 789.2K | |
| Working Capital Per Employee | 131.7K | |
| Working Capital Per Executive | 625.8K |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 0.846 | Quarterly Revenue Growth 0.234 | Return On Assets (0.23) | Return On Equity (0.64) |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.